Find the Perfect Plan for Your Investment Journey
B
Latest price
52 Week Range
CA$0.17 - CA$0.69
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CA$53.09M |
EV | CA$58.62M |
Shares Outstanding | 116.89M |
Beta | 1.61 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2024E | - |
P/Revenue 2024E | - |
Revenue | 2.50% |
EPS | 31.50% |
Operating Cash Flow | 20.30% |
Free Cash Flow | 16.30% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2024E | - |
Net Profit Margin 2024E | - |
ROE 2024E | - |
ROCE 2023 | - |
DPS 2024E | - |
Payout Ratio 2024E | - |
Div. Yield 2024E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
B
BioNxt Solutions Inc.
BNXT
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Probst, Wolfgang
Employees
Website
www.bionxt.comIPO Date
2019-08-06
Headquarters
1820 Fir Street, Suite 270, Vancouver, British Columbia, V6J 3B1, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved